|
|
 |
|  |
|
Home > Drug Companies > Ortho McNeil Pharmaceutical Corp.
Ortho-McNeil Pharmaceutical Corp.
A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.
Ortho-McNeil, Inc. is focused on providing the most innovative, safe and effective treatments and unsurpassed quality to advance patient care. They are involved in hospital and institutional settings. They also recently launched a new unit, PriCara, Unit of Ortho-McNeil, Inc. dedicated to serving Primary Care providers because they feel they play a unique and vital role on the frontline of medicine. Ortho-McNeil currently provides products to treat pain, acid reflux disease and infectious diseases. They continue to explore new opportunities to develop solutions for unmet health care needs in primary care. Ortho-McNeil is headquartered in Raritan, New Jersey. Ortho-McNeil supports efforts to provide patients with access to prescription medications and participates in Medicare Rx, Together Rx Access, and Partnership for Prescription Assistance. Ortho-McNeil Pharmaceutical Corp. manufactures the products like as Aciphex rabeprazole sodium, Floxin, Nizoral Shampoo etc. In that include Propulsid limited access program which contains is no longer available through retail pharmacies. The only way doctors can obtain cisapride is through a limited-access program developed together by Janssen Pharmaceutica and the U.S. Food and Drug Administration. This program was created to ensure that only appropriate patients receive the medication. Ortho-McNeil, Inc. strives to provide innovative, high quality, safe and effective treatments to healthcare providers in primary care, hospitals and other care facilities.
Back to Drug Companies
|
|
 |
|
 |
|
|
|